Modeling IL-1 induced degradation of articular cartilage

Saptarshi Kar, David Smith, Bruce Gardiner, Y. Li, Y. Wang, A.J. Grodzinsky

    Research output: Contribution to journalArticle

    11 Citations (Scopus)
    137 Downloads (Pure)

    Abstract

    © 2016 Elsevier Inc. All rights reserved. In this study, we develop a computational model to simulate the in vitro biochemical degradation of articular cartilage explants sourced from the femoropatellar grooves of bovine calves. Cartilage explants were incubated in culture medium with and without the inflammatory cytokine IL-1a. The spatio-temporal evolution of the cartilage explant's extracellular matrix components is modelled. Key variables in the model include chondrocytes, aggrecan, collagen, aggrecanase, collagenase and IL-1a. The model is first calibrated for aggrecan homeostasis of cartilage in vivo, then for data on (explant) controls, and finally for data on the IL-1a driven proteolysis of aggrecan and collagen over a 4-week period. The model was found to fit the experimental data best when: (i) chondrocytes continue to synthesize aggrecan during the cytokine challenge, (ii) a one to two day delay is introduced between the addition of IL-1a to the culture medium and subsequent aggrecanolysis, (iii) collagen degradation does not commence until the total concentration of aggrecan (i.e. both intact and degraded aggrecan) at any specific location within the explant becomes =1.5 mg/ml and (iv) degraded aggrecan formed due to the IL-1a induced proteolysis of intact aggrecan protects the collagen network while collagen degrades in a two-step process which, together, significantly modulate the collagen network degradation. Under simulated in vivo conditions, the model predicts increased aggrecan turnover rates in the presence of synovial IL-1a, consistent with experimental observations. Such models may help to infer the course of events in vivo following traumatic joint injury, and may also prove useful in quantitatively evaluating the efficiency of various therapeutic molecules that could be employed to avoid or modify the course of cartilage disease states.
    Original languageEnglish
    Pages (from-to)37-53
    Number of pages17
    JournalArchives of Biochemistry and Biophysics
    Volume594
    Early online date10 Feb 2016
    DOIs
    Publication statusPublished - 15 Mar 2016

    Fingerprint

    Aggrecans
    Cartilage
    Articular Cartilage
    Interleukin-1
    Degradation
    Collagen
    Proteolysis
    Chondrocytes
    Culture Media
    Cartilage Diseases
    Cytokines
    Collagenases
    Extracellular Matrix
    Homeostasis
    Joints
    Molecules

    Cite this

    Kar, Saptarshi ; Smith, David ; Gardiner, Bruce ; Li, Y. ; Wang, Y. ; Grodzinsky, A.J. / Modeling IL-1 induced degradation of articular cartilage. In: Archives of Biochemistry and Biophysics. 2016 ; Vol. 594. pp. 37-53.
    @article{da5d829fbf4d4f9daccab2e33766a33a,
    title = "Modeling IL-1 induced degradation of articular cartilage",
    abstract = "{\circledC} 2016 Elsevier Inc. All rights reserved. In this study, we develop a computational model to simulate the in vitro biochemical degradation of articular cartilage explants sourced from the femoropatellar grooves of bovine calves. Cartilage explants were incubated in culture medium with and without the inflammatory cytokine IL-1a. The spatio-temporal evolution of the cartilage explant's extracellular matrix components is modelled. Key variables in the model include chondrocytes, aggrecan, collagen, aggrecanase, collagenase and IL-1a. The model is first calibrated for aggrecan homeostasis of cartilage in vivo, then for data on (explant) controls, and finally for data on the IL-1a driven proteolysis of aggrecan and collagen over a 4-week period. The model was found to fit the experimental data best when: (i) chondrocytes continue to synthesize aggrecan during the cytokine challenge, (ii) a one to two day delay is introduced between the addition of IL-1a to the culture medium and subsequent aggrecanolysis, (iii) collagen degradation does not commence until the total concentration of aggrecan (i.e. both intact and degraded aggrecan) at any specific location within the explant becomes =1.5 mg/ml and (iv) degraded aggrecan formed due to the IL-1a induced proteolysis of intact aggrecan protects the collagen network while collagen degrades in a two-step process which, together, significantly modulate the collagen network degradation. Under simulated in vivo conditions, the model predicts increased aggrecan turnover rates in the presence of synovial IL-1a, consistent with experimental observations. Such models may help to infer the course of events in vivo following traumatic joint injury, and may also prove useful in quantitatively evaluating the efficiency of various therapeutic molecules that could be employed to avoid or modify the course of cartilage disease states.",
    author = "Saptarshi Kar and David Smith and Bruce Gardiner and Y. Li and Y. Wang and A.J. Grodzinsky",
    year = "2016",
    month = "3",
    day = "15",
    doi = "10.1016/j.abb.2016.02.008",
    language = "English",
    volume = "594",
    pages = "37--53",
    journal = "Archives of Biochem and Biophysics",
    issn = "0003-9861",
    publisher = "Academic Press",

    }

    Modeling IL-1 induced degradation of articular cartilage. / Kar, Saptarshi; Smith, David; Gardiner, Bruce; Li, Y.; Wang, Y.; Grodzinsky, A.J.

    In: Archives of Biochemistry and Biophysics, Vol. 594, 15.03.2016, p. 37-53.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Modeling IL-1 induced degradation of articular cartilage

    AU - Kar, Saptarshi

    AU - Smith, David

    AU - Gardiner, Bruce

    AU - Li, Y.

    AU - Wang, Y.

    AU - Grodzinsky, A.J.

    PY - 2016/3/15

    Y1 - 2016/3/15

    N2 - © 2016 Elsevier Inc. All rights reserved. In this study, we develop a computational model to simulate the in vitro biochemical degradation of articular cartilage explants sourced from the femoropatellar grooves of bovine calves. Cartilage explants were incubated in culture medium with and without the inflammatory cytokine IL-1a. The spatio-temporal evolution of the cartilage explant's extracellular matrix components is modelled. Key variables in the model include chondrocytes, aggrecan, collagen, aggrecanase, collagenase and IL-1a. The model is first calibrated for aggrecan homeostasis of cartilage in vivo, then for data on (explant) controls, and finally for data on the IL-1a driven proteolysis of aggrecan and collagen over a 4-week period. The model was found to fit the experimental data best when: (i) chondrocytes continue to synthesize aggrecan during the cytokine challenge, (ii) a one to two day delay is introduced between the addition of IL-1a to the culture medium and subsequent aggrecanolysis, (iii) collagen degradation does not commence until the total concentration of aggrecan (i.e. both intact and degraded aggrecan) at any specific location within the explant becomes =1.5 mg/ml and (iv) degraded aggrecan formed due to the IL-1a induced proteolysis of intact aggrecan protects the collagen network while collagen degrades in a two-step process which, together, significantly modulate the collagen network degradation. Under simulated in vivo conditions, the model predicts increased aggrecan turnover rates in the presence of synovial IL-1a, consistent with experimental observations. Such models may help to infer the course of events in vivo following traumatic joint injury, and may also prove useful in quantitatively evaluating the efficiency of various therapeutic molecules that could be employed to avoid or modify the course of cartilage disease states.

    AB - © 2016 Elsevier Inc. All rights reserved. In this study, we develop a computational model to simulate the in vitro biochemical degradation of articular cartilage explants sourced from the femoropatellar grooves of bovine calves. Cartilage explants were incubated in culture medium with and without the inflammatory cytokine IL-1a. The spatio-temporal evolution of the cartilage explant's extracellular matrix components is modelled. Key variables in the model include chondrocytes, aggrecan, collagen, aggrecanase, collagenase and IL-1a. The model is first calibrated for aggrecan homeostasis of cartilage in vivo, then for data on (explant) controls, and finally for data on the IL-1a driven proteolysis of aggrecan and collagen over a 4-week period. The model was found to fit the experimental data best when: (i) chondrocytes continue to synthesize aggrecan during the cytokine challenge, (ii) a one to two day delay is introduced between the addition of IL-1a to the culture medium and subsequent aggrecanolysis, (iii) collagen degradation does not commence until the total concentration of aggrecan (i.e. both intact and degraded aggrecan) at any specific location within the explant becomes =1.5 mg/ml and (iv) degraded aggrecan formed due to the IL-1a induced proteolysis of intact aggrecan protects the collagen network while collagen degrades in a two-step process which, together, significantly modulate the collagen network degradation. Under simulated in vivo conditions, the model predicts increased aggrecan turnover rates in the presence of synovial IL-1a, consistent with experimental observations. Such models may help to infer the course of events in vivo following traumatic joint injury, and may also prove useful in quantitatively evaluating the efficiency of various therapeutic molecules that could be employed to avoid or modify the course of cartilage disease states.

    U2 - 10.1016/j.abb.2016.02.008

    DO - 10.1016/j.abb.2016.02.008

    M3 - Article

    VL - 594

    SP - 37

    EP - 53

    JO - Archives of Biochem and Biophysics

    JF - Archives of Biochem and Biophysics

    SN - 0003-9861

    ER -